Express News | Jinling Pharmaceutical: Magnesium sulfate injection has obtained a pharmaceutical registration certificate.

BreakingsDec 11 16:28

Express News | Today, a total of 80 stocks in the A-share market experienced block trades, with shanghai new world, guangdong aofei data technology, and jinling pharmaceutical leading in transaction volume.

BreakingsNov 29 20:44

Jinling Pharmaceutical Completes Cancellation of Subsidiary

MT NewswiresNov 21 14:32

Express News | 1.824 billion yuan market cap restricted shares will be lifted today, with Deguan New Materials, jinling pharmaceutical, and Wangcheng technology leading the way in market value lifting.

BreakingsOct 30 07:39

Jinling Pharmaceutical: Report for the third quarter of 2024

SZSIOct 29 00:00 · Announcements

Jinling Pharmaceutical (000919.SZ): Intends to acquire a portion of shares of Xingong Fund and equity of non-cash distribution of Xingong Fund.

Gelonghui, October 21st | Jinling Pharmaceutical (000919.SZ) announced that in order to build the company's global strategy of "medical and health care dual platform", improve the company's medical regional market layout, and address the competition between Nanjing NewVenture Investment Group Co., Ltd. (referred to as "NewVenture Group") controlling Nanjing Meishan Hospital Co., Ltd. (referred to as "Nanjing Meishan Hospital") and the company, the company plans to acquire 28.46% of the shares of the Nanjing NewVenture Medical Industry Investment Fund Partnership Enterprise (Limited Partnership) (referred to as "fund" or "NewVenture Fund") held by NewVenture Group for 164.7317 million yuan.

Gelonghui FinanceOct 21 19:00